CALLIO
LIVE

Serial Number

99357964

Owner

Callio Operating Co, Inc.

Attorney

Joyce Liou

Filing Date

Aug 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CALLIO Trademark

Serial Number: 99357964

CALLIO is a trademark filed by Callio Operating Co, Inc. on August 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Callio Operating Co, Inc. (4 trademarks)

1201 3rd Ave, Suite 2200-124
Seattle, WA 98101

Entity Type: 03

Trademark Details

Filing Date

August 26, 2025

Registration Date

Not Registered

Goods & Services

Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials

Pharmaceutical and biological preparations; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology

Custom manufacturing of pharmaceuticals and therapeutic agents for medical use

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 15, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 26, 2025 MAFR
NEW APPLICATION ENTERED
Aug 26, 2025 NWAP